Sabra Healthcare REIT, Inc. $SBRA Shares Purchased by Graham Capital Management L.P.

Key Points

• Graham Capital Management L.P. increased its holdings in Sabra Healthcare REIT by 37.8% during the first quarter, owning a total of 276,544 shares worth approximately $4.83 million.
• Several other institutional investors also adjusted their positions, with Jefferies Financial Group growing its stake by over 7,196%, now holding 1.46 million shares.
• Sabra Healthcare REIT reported stronger-than-expected earnings of $0.38 per share, exceeding the consensus estimate of $0.36, alongside quarterly revenue of $189.15 million.

Graham Capital Management L.P. increased its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 37.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 276,544 shares of the real estate investment trust's stock after acquiring an additional 75,893 shares during the period. Graham Capital Management L.P. owned about 0.12% of Sabra Healthcare REIT worth $4,831,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. SVB Wealth LLC acquired a new stake in Sabra Healthcare REIT during the first quarter worth about $34,000. UMB Bank n.a. grew its holdings in Sabra Healthcare REIT by 379.6% during the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after acquiring an additional 1,621 shares during the period. Wealth Preservation Advisors LLC acquired a new stake in Sabra Healthcare REIT during the first quarter worth about $38,000. Northwestern Mutual Wealth Management Co. grew its holdings in Sabra Healthcare REIT by 61.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust's stock worth $49,000 after acquiring an additional 1,065 shares during the period. Finally, Assetmark Inc. grew its holdings in Sabra Healthcare REIT by 37.8% during the first quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock worth $63,000 after acquiring an additional 989 shares during the period. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Price Performance

SBRA traded up $0.15 during trading on Tuesday, hitting $19.26. The company's stock had a trading volume of 2,260,462 shares, compared to its average volume of 2,586,047. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a twelve month low of $15.60 and a twelve month high of $20.03. The business's fifty day simple moving average is $18.58 and its 200 day simple moving average is $17.83. The firm has a market capitalization of $4.62 billion, a price-to-earnings ratio of 25.34, a P/E/G ratio of 1.52 and a beta of 0.88.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, beating the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The company had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. During the same period last year, the company earned $0.36 earnings per share. Sabra Healthcare REIT's quarterly revenue was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.2%. Sabra Healthcare REIT's payout ratio is currently 157.89%.

Analyst Upgrades and Downgrades

Several research firms recently commented on SBRA. BMO Capital Markets raised their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a report on Monday, August 25th. Scotiabank raised their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. JMP Securities raised their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a report on Wednesday, August 6th. Finally, Wells Fargo & Company raised their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a report on Wednesday, August 27th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $20.43.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.